Studies on the betacellulin receptor in pancreatic AR42J cells

N. Ishiyama, M. Kanzaki, Masaharu Seno, H. Yamada, I. Kobayashi, I. Kojima

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Betacellulin is a member of the epidermal growth factor family and converts pancreatic AR42J cells into insulin-producing cells. This study was conducted to characterise the receptor for betacellulin in AR42J cells. AR42J cells expressed two classes of binding sites for radioactive iodine labelled betacellulin, with Kd values of 4.6 x 10-11 mol/l and 3.0 x 10-10 mol/l. The binding of [125I]betacellulin was inhibited by unlabelled betacellulin in a dose-dependent manner, but epidermal growth factor was 50 fold less effective than betacellulin. Affinity cross-linking showed a [125I]betacellulin-binding protein with a molecular weight of approximately 180 KDa. When this protein was immunoprecipitated with antibody against epidermal growth factor receptors ErbB-1, ErbB-2, ErbB-3 or ErbB-4, it was immunoprecipitated only by the anti-ErbB-1 antibody. When the [125I]betacellulin-labelled proteins were immunoprecipitated with a combination of the four ErbB antibodies, and the unprecipitated proteins were then immunoprecipitated with anti-phosphotyrosine antibody, a 190 KDa protein was observed. Betacellulin induced the tyrosine phosphorylation of ErbB-1, ErbB-2 and ErbB-4. Finally, while 100 pmol/l betacellulin converted all of the AR42J into insulin-producing cells in the presence of activin A, 10 nmol/l epidermal growth factor induced differentiation in only about 30% of the cells. Higher concentrations of epidermal growth factor were less effective. Neu differentiation factor in the presence or absence of epidermal growth factor was ineffective. These results indicate that betacellulin binds to ErbB-1 and possibly another protein with a molecular weight of 190 KDa. The latter betacellulin-binding protein may be involved in the differentiation-inducing activity of betacellulin.

Original languageEnglish
Pages (from-to)623-628
Number of pages6
JournalDiabetologia
Volume41
Issue number6
DOIs
Publication statusPublished - 1998

Fingerprint

Epidermal Growth Factor
Proteins
Betacellulin
Antibodies
Carrier Proteins
Molecular Weight
Insulin
Neuregulin-1
Phosphotyrosine
Iodine
Tyrosine
Anti-Idiotypic Antibodies
Binding Sites
Phosphorylation

Keywords

  • Betacellulin
  • Differentiation
  • Epidermal growth factor
  • Epidermal growth factor receptor
  • ErbB

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Ishiyama, N., Kanzaki, M., Seno, M., Yamada, H., Kobayashi, I., & Kojima, I. (1998). Studies on the betacellulin receptor in pancreatic AR42J cells. Diabetologia, 41(6), 623-628. https://doi.org/10.1007/s001250050959

Studies on the betacellulin receptor in pancreatic AR42J cells. / Ishiyama, N.; Kanzaki, M.; Seno, Masaharu; Yamada, H.; Kobayashi, I.; Kojima, I.

In: Diabetologia, Vol. 41, No. 6, 1998, p. 623-628.

Research output: Contribution to journalArticle

Ishiyama, N, Kanzaki, M, Seno, M, Yamada, H, Kobayashi, I & Kojima, I 1998, 'Studies on the betacellulin receptor in pancreatic AR42J cells', Diabetologia, vol. 41, no. 6, pp. 623-628. https://doi.org/10.1007/s001250050959
Ishiyama N, Kanzaki M, Seno M, Yamada H, Kobayashi I, Kojima I. Studies on the betacellulin receptor in pancreatic AR42J cells. Diabetologia. 1998;41(6):623-628. https://doi.org/10.1007/s001250050959
Ishiyama, N. ; Kanzaki, M. ; Seno, Masaharu ; Yamada, H. ; Kobayashi, I. ; Kojima, I. / Studies on the betacellulin receptor in pancreatic AR42J cells. In: Diabetologia. 1998 ; Vol. 41, No. 6. pp. 623-628.
@article{3ae06738112c4d76b0eb9a042d3a211e,
title = "Studies on the betacellulin receptor in pancreatic AR42J cells",
abstract = "Betacellulin is a member of the epidermal growth factor family and converts pancreatic AR42J cells into insulin-producing cells. This study was conducted to characterise the receptor for betacellulin in AR42J cells. AR42J cells expressed two classes of binding sites for radioactive iodine labelled betacellulin, with Kd values of 4.6 x 10-11 mol/l and 3.0 x 10-10 mol/l. The binding of [125I]betacellulin was inhibited by unlabelled betacellulin in a dose-dependent manner, but epidermal growth factor was 50 fold less effective than betacellulin. Affinity cross-linking showed a [125I]betacellulin-binding protein with a molecular weight of approximately 180 KDa. When this protein was immunoprecipitated with antibody against epidermal growth factor receptors ErbB-1, ErbB-2, ErbB-3 or ErbB-4, it was immunoprecipitated only by the anti-ErbB-1 antibody. When the [125I]betacellulin-labelled proteins were immunoprecipitated with a combination of the four ErbB antibodies, and the unprecipitated proteins were then immunoprecipitated with anti-phosphotyrosine antibody, a 190 KDa protein was observed. Betacellulin induced the tyrosine phosphorylation of ErbB-1, ErbB-2 and ErbB-4. Finally, while 100 pmol/l betacellulin converted all of the AR42J into insulin-producing cells in the presence of activin A, 10 nmol/l epidermal growth factor induced differentiation in only about 30{\%} of the cells. Higher concentrations of epidermal growth factor were less effective. Neu differentiation factor in the presence or absence of epidermal growth factor was ineffective. These results indicate that betacellulin binds to ErbB-1 and possibly another protein with a molecular weight of 190 KDa. The latter betacellulin-binding protein may be involved in the differentiation-inducing activity of betacellulin.",
keywords = "Betacellulin, Differentiation, Epidermal growth factor, Epidermal growth factor receptor, ErbB",
author = "N. Ishiyama and M. Kanzaki and Masaharu Seno and H. Yamada and I. Kobayashi and I. Kojima",
year = "1998",
doi = "10.1007/s001250050959",
language = "English",
volume = "41",
pages = "623--628",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Studies on the betacellulin receptor in pancreatic AR42J cells

AU - Ishiyama, N.

AU - Kanzaki, M.

AU - Seno, Masaharu

AU - Yamada, H.

AU - Kobayashi, I.

AU - Kojima, I.

PY - 1998

Y1 - 1998

N2 - Betacellulin is a member of the epidermal growth factor family and converts pancreatic AR42J cells into insulin-producing cells. This study was conducted to characterise the receptor for betacellulin in AR42J cells. AR42J cells expressed two classes of binding sites for radioactive iodine labelled betacellulin, with Kd values of 4.6 x 10-11 mol/l and 3.0 x 10-10 mol/l. The binding of [125I]betacellulin was inhibited by unlabelled betacellulin in a dose-dependent manner, but epidermal growth factor was 50 fold less effective than betacellulin. Affinity cross-linking showed a [125I]betacellulin-binding protein with a molecular weight of approximately 180 KDa. When this protein was immunoprecipitated with antibody against epidermal growth factor receptors ErbB-1, ErbB-2, ErbB-3 or ErbB-4, it was immunoprecipitated only by the anti-ErbB-1 antibody. When the [125I]betacellulin-labelled proteins were immunoprecipitated with a combination of the four ErbB antibodies, and the unprecipitated proteins were then immunoprecipitated with anti-phosphotyrosine antibody, a 190 KDa protein was observed. Betacellulin induced the tyrosine phosphorylation of ErbB-1, ErbB-2 and ErbB-4. Finally, while 100 pmol/l betacellulin converted all of the AR42J into insulin-producing cells in the presence of activin A, 10 nmol/l epidermal growth factor induced differentiation in only about 30% of the cells. Higher concentrations of epidermal growth factor were less effective. Neu differentiation factor in the presence or absence of epidermal growth factor was ineffective. These results indicate that betacellulin binds to ErbB-1 and possibly another protein with a molecular weight of 190 KDa. The latter betacellulin-binding protein may be involved in the differentiation-inducing activity of betacellulin.

AB - Betacellulin is a member of the epidermal growth factor family and converts pancreatic AR42J cells into insulin-producing cells. This study was conducted to characterise the receptor for betacellulin in AR42J cells. AR42J cells expressed two classes of binding sites for radioactive iodine labelled betacellulin, with Kd values of 4.6 x 10-11 mol/l and 3.0 x 10-10 mol/l. The binding of [125I]betacellulin was inhibited by unlabelled betacellulin in a dose-dependent manner, but epidermal growth factor was 50 fold less effective than betacellulin. Affinity cross-linking showed a [125I]betacellulin-binding protein with a molecular weight of approximately 180 KDa. When this protein was immunoprecipitated with antibody against epidermal growth factor receptors ErbB-1, ErbB-2, ErbB-3 or ErbB-4, it was immunoprecipitated only by the anti-ErbB-1 antibody. When the [125I]betacellulin-labelled proteins were immunoprecipitated with a combination of the four ErbB antibodies, and the unprecipitated proteins were then immunoprecipitated with anti-phosphotyrosine antibody, a 190 KDa protein was observed. Betacellulin induced the tyrosine phosphorylation of ErbB-1, ErbB-2 and ErbB-4. Finally, while 100 pmol/l betacellulin converted all of the AR42J into insulin-producing cells in the presence of activin A, 10 nmol/l epidermal growth factor induced differentiation in only about 30% of the cells. Higher concentrations of epidermal growth factor were less effective. Neu differentiation factor in the presence or absence of epidermal growth factor was ineffective. These results indicate that betacellulin binds to ErbB-1 and possibly another protein with a molecular weight of 190 KDa. The latter betacellulin-binding protein may be involved in the differentiation-inducing activity of betacellulin.

KW - Betacellulin

KW - Differentiation

KW - Epidermal growth factor

KW - Epidermal growth factor receptor

KW - ErbB

UR - http://www.scopus.com/inward/record.url?scp=0031811912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031811912&partnerID=8YFLogxK

U2 - 10.1007/s001250050959

DO - 10.1007/s001250050959

M3 - Article

C2 - 9662041

AN - SCOPUS:0031811912

VL - 41

SP - 623

EP - 628

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 6

ER -